(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The product was not returned to abbott vascular for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.There was no reported device malfunction.The reported patient effects of angina, dyspnea, dizziness, and stenosis are listed in the xience pro a instructions for use, as known patient effects.A conclusive cause for the patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
|
It was reported that the procedure on (b)(6) 2018 was to treat a de novo lesion located in the mid right coronary artery (rca) with 90% stenosis.A 4.0x28 mm xience alpine stent was implanted.On (b)(6) 2019 the patient went to the emergency room with shortness of breath, dizziness, and arm pain that were diagnosed as angina.On (b)(4) 2019 percutaneous coronary intervention was performed to revascularize the restenosis in the rca target lesion.A non-target lesion was also treated.The condition resolved on (b)(6) 2019.No additional information was provided.
|